DEFDOPA TABLET

Product Description

DEFDOPA TABLET combines Levodopa 100 mg and Carbidopa 25 mg in a scientifically balanced formulation designed for effective management of Parkinsons disease and movement disorders. This combination enhances dopamine levels in the brain, helping to control symptoms such as tremors, rigidity, and bradykinesia.

Manufactured in WHO-GMP certified facilities, DEFDOPA guarantees consistent quality, ensuring better patient compliance and therapeutic outcomes. It is an essential product for neurology clinics, hospital pharmacies, and bulk pharmaceutical distributors.

Key Benefits:

• Enhances dopamine synthesis to improve motor function

• Reduces Parkinsonian symptoms including tremors and stiffness

• Carbidopa improves Levodopa efficacy and minimizes peripheral side effects

• Well-tolerated with proven clinical efficacy

Applications:

• Treatment of Parkinsons disease and parkinsonism syndromes

• Used for managing motor fluctuations and dopamine deficiency

• Recommended in neurology and movement disorder therapy

Ideal For:

• Pharmaceutical wholesalers, retailers, and hospital supply chains

• Bulk buyers and B2B distributors looking for high-demand neurological medicines